You wrote "On a more general point. Dendritic Cell vaccines of all forms are better at preventing spread than killing in bulk. That makes response rate a poor metric." That was true until the activation method in Direct showed up and a deeper understanding of DC subsets revealed some very interesting findings. Big pharma is not happy that they are so far behind in their understanding of DC control of immune response. Best wishes.
Market Data 
Markets 
AI
